Savara Inc Available-for-sale Securities, Noncurrent
Savara Inc (SVRA) had Available-for-sale Securities, Noncurrent of $0 as of 2016-12-31, per its 10-K filed 2017-03-06.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesNoncurrent · last filed 2017-03-06
- 2016-12-31: Available-for-sale Securities, Noncurrent $0.00.
- 2016-09-30: Available-for-sale Securities, Noncurrent $0.00.
- 2016-06-30: Available-for-sale Securities, Noncurrent $0.00.
- 2015-12-31: Available-for-sale Securities, Noncurrent $2.70M.
| Period end | Available-for-sale Securities, Noncurrent | Available-for-sale Securities, Noncurrent as first filed |
|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-06 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-09 | |
| 2015-12-31 | $2.70M 10-K · filed 2017-03-06 | |
| 2015-09-30 | $2.20M 10-Q · filed 2016-05-06 | $2.90M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $5.60M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $5.10M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $4.70M 10-K · filed 2015-03-24 | |
| 2014-09-30 | $4.50M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $3.70M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $4.20M 10-Q · filed 2014-05-05 | |
| 2013-12-31 | $2.90M 10-K · filed 2014-03-26 | |
| 2013-09-30 | $2.50M 10-Q · filed 2013-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |